Skip Nav Destination
Issues
August 2017
ISSN 2296-5270
EISSN 2296-5262
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 7-8
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 397–400.
https://doi.org/10.1159/000479461
Editorial
Advances in Cancer Therapy: Liquid Biopsy
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 402–403.
https://doi.org/10.1159/000479186
Review Article
Liquid Biopsy: Current Status and Future Perspectives
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 404–408.
https://doi.org/10.1159/000478018
Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 409–416.
https://doi.org/10.1159/000478864
Circulating Tumor Cells in Esophageal Cancer
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 417–422.
https://doi.org/10.1159/000478863
Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 423–429.
https://doi.org/10.1159/000478019
Liquid Biopsy: Value for Melanoma Therapy?
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 430–434.
https://doi.org/10.1159/000478893
Original Article
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536
Subject Area:
Oncology
Frank Breitenbuecher; Joachim von Pawel; Martin Sebastian; Cornelius Kortsik; Saskia Ting; Stefan Kasper; Jeremias Wohlschläger; Karl Worm; Alicia Morresi-Hauf; Arno Schad; Daniela Westerwick; Beatrice Wehler; Martin Werner; Gerd Munzert; Birgit Gaschler-Markefski; Kurt W. Schmid; Martin Schuler
Oncol Res Treat (2017) 40 (7-8): 435–439.
https://doi.org/10.1159/000475503
Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 441–445.
https://doi.org/10.1159/000473880
Novel Insights from Clinical Practice
Potential Role of the PD-1/PD-L1 Axis in the Immune Regulation of Chronic GVHD
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 447–450.
https://doi.org/10.1159/000471768
Erratum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 451.
https://doi.org/10.1159/000477509
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 453–458.
https://doi.org/10.1159/000479275
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 460–461.
https://doi.org/10.1159/000479413
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 462–463.
https://doi.org/10.1159/000479414
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 464–465.
https://doi.org/10.1159/000479415
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 467.
https://doi.org/10.1159/000479416
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 468–473.
https://doi.org/10.1159/000479417
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (7-8): 474–476.
https://doi.org/10.1159/000479274
